148 related articles for article (PubMed ID: 10411579)
1. Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.
Gauthier C; Tavernier G; Trochu JN; Leblais V; Laurent K; Langin D; Escande D; Le Marec H
J Pharmacol Exp Ther; 1999 Aug; 290(2):687-93. PubMed ID: 10411579
[TBL] [Abstract][Full Text] [Related]
2. Functional beta3-adrenoceptor in the human heart.
Gauthier C; Tavernier G; Charpentier F; Langin D; Le Marec H
J Clin Invest; 1996 Jul; 98(2):556-62. PubMed ID: 8755668
[TBL] [Abstract][Full Text] [Related]
3. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
4. beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
Tavernier G; Toumaniantz G; Erfanian M; Heymann MF; Laurent K; Langin D; Gauthier C
Cardiovasc Res; 2003 Aug; 59(2):288-96. PubMed ID: 12909312
[TBL] [Abstract][Full Text] [Related]
5. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
Kong YH; Li WM; Tian Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
[TBL] [Abstract][Full Text] [Related]
6. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
8. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
[TBL] [Abstract][Full Text] [Related]
9. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium.
Napp A; Brixius K; Pott C; Ziskoven C; Boelck B; Mehlhorn U; Schwinger RH; Bloch W
J Card Fail; 2009 Feb; 15(1):57-67. PubMed ID: 19181295
[TBL] [Abstract][Full Text] [Related]
10. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Chen J; Zhang LF; Han C; Yu GS; Ma J
J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
[TBL] [Abstract][Full Text] [Related]
11. Existence of beta(3)-adrenoceptors in rat heart: functional implications.
Barbier J; Mouas C; Rannou-Bekono F; Carré F
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):796-8. PubMed ID: 17600560
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
Hillman KL; Doze VA; Porter JE
J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513
[TBL] [Abstract][Full Text] [Related]
13. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
14. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
15. Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.
Audigane L; Kerfant BG; El Harchi A; Lorenzen-Schmidt I; Toumaniantz G; Cantereau A; Potreau D; Charpentier F; Noireaud J; Gauthier C
Exp Physiol; 2009 Apr; 94(4):400-11. PubMed ID: 19151075
[TBL] [Abstract][Full Text] [Related]
16. Species-dependent differences in inotropic effects and phosphoinositide hydrolysis induced by endothelin-3 in mammalian ventricular myocardium.
Yang HT; Zhu Y; Endoh M
Br J Pharmacol; 1997 Apr; 120(8):1497-504. PubMed ID: 9113371
[TBL] [Abstract][Full Text] [Related]
17. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the beta-adrenoceptor subtype involved in mediation of glucose transport in L6 cells.
Nevzorova J; Bengtsson T; Evans BA; Summers RJ
Br J Pharmacol; 2002 Sep; 137(1):9-18. PubMed ID: 12183326
[TBL] [Abstract][Full Text] [Related]
19. β3-Adrenoceptor-mediated responses in diabetic rat heart.
Kayki-Mutlu G; Arioglu-Inan E; Ozakca I; Ozcelikay AT; Altan VM
Gen Physiol Biophys; 2014; 33(1):99-109. PubMed ID: 24334532
[TBL] [Abstract][Full Text] [Related]
20. Induction of beta3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes.
Germack R; Dickenson JM
J Pharmacol Exp Ther; 2006 Jan; 316(1):392-402. PubMed ID: 16183708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
